CC-42344 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza A
Conditions
Influenza A
Trial Timeline
Feb 11, 2022 → Mar 29, 2023
NCT ID
NCT05202379About CC-42344 + Placebo
CC-42344 + Placebo is a phase 1 stage product being developed by Cocrystal Pharma for Influenza A. The current trial status is completed. This product is registered under clinical trial identifier NCT05202379. Target conditions include Influenza A.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05202379 | Phase 1 | Completed |
Competing Products
20 competing products in Influenza A